ID
4901
Descripción
ODM derived from http://clinicaltrials.gov/show/NCT00359762
Link
http://clinicaltrials.gov/show/NCT00359762
Palabras clave
Versiones (3)
- 22/3/12 22/3/12 -
- 14/4/14 14/4/14 - Julian Varghese
- 20/9/21 20/9/21 -
Subido en
14 de abril de 2014
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY 4.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility NCT00359762 Type 2 Diabetes Mellitus
Eligibility
- StudyEvent: Eligibility
Descripción
Exclusion Criteria
Descripción
Participated in an interventional medical, surgical, or pharmaceutical study within 30 days prior to screening.
Tipo de datos
boolean
Alias
- UMLS CUI 2011AA
- C2348568
Descripción
Characteristics contraindicating metformin or glimepiride use.
Tipo de datos
boolean
Alias
- UMLS CUI 2011AA
- C1301624
- SNOMED CT 2011_0131
- 397745006
- UMLS CUI 2011AA
- C0025598
- SNOMED CT 2011_0131
- 372567009
- LOINC Version 232
- MTHU016062
- UMLS CUI 2011AA
- C0061323
- SNOMED CT 2011_0131
- 386966003
- LOINC Version 232
- MTHU018302
Descripción
Receiving drugs that directly affect gastrointestinal motility.
Tipo de datos
boolean
Alias
- UMLS CUI 2011AA
- C0013227
- UMLS CUI 2011AA
- C0017184
Descripción
Receiving chronic (lasting longer than 2 weeks) systemic glucocorticoid therapy.
Tipo de datos
boolean
Alias
- UMLS CUI 2011AA
- C0205191
- SNOMED CT 2011_0131
- 90734009
- UMLS CUI 2011AA
- CL383594
Descripción
Have used any prescription drug to promote weight loss within 3 months prior to screening.
Tipo de datos
boolean
Alias
- UMLS CUI 2011AA
- C0013227
- UMLS CUI 2011AA
- C0043096
- SNOMED CT 2011_0131
- 89362005
- MedDRA 14.1
- 10047895
- LOINC Version 232
- MTHU020881
- ICD-9-CM Version 2011
- 783.21
- CTCAE 1105E
- E12228
Descripción
Treated for longer than 2 weeks with any of the following medications within 3 months prior to screening: insulin, thiazolidinediones, alpha-glucosidase inhibitors, sulfonylurea, meglitinides
Tipo de datos
boolean
Alias
- UMLS CUI 2011AA
- C0013227
- UMLS CUI 2011AA
- C0021641
- SNOMED CT 2011_0131
- 67866001
- LOINC Version 232
- MTHU019392
- UMLS CUI 2011AA
- C1257987
- SNOMED CT 2011_0131
- 109086001
- UMLS CUI 2011AA
- C2267008
- UMLS CUI 2011AA
- C0038766
- UMLS CUI 2011AA
- C1579432
Similar models
Eligibility
- StudyEvent: Eligibility
397669002 (SNOMED CT 2011_0131)
439401001 (SNOMED CT 2011_0131)
MTHU008876 (LOINC Version 232)
C0011860 (UMLS CUI 2011AA)
44054006 (SNOMED CT 2011_0131)
10012613 (MedDRA 14.1)
E08-E13 (ICD-10-CM Version 2010)
41829006 (SNOMED CT 2011_0131)
C0015259 (UMLS CUI 2011AA)
256235009 (SNOMED CT 2011_0131)
10015634 (MedDRA 14.1)
C0205360 (UMLS CUI 2011AA)
58158008 (SNOMED CT 2011_0131)
MTHU015276 (LOINC Version 232)
C0013227 (UMLS CUI 2011AA)
C0025598 (UMLS CUI 2011AA)
372567009 (SNOMED CT 2011_0131)
MTHU016062 (LOINC Version 232)
140075008 (SNOMED CT 2011_0131)
10005894 (MedDRA 14.1)
LP35925-4 (LOINC Version 232)
397745006 (SNOMED CT 2011_0131)
C0025598 (UMLS CUI 2011AA)
372567009 (SNOMED CT 2011_0131)
MTHU016062 (LOINC Version 232)
C0061323 (UMLS CUI 2011AA)
386966003 (SNOMED CT 2011_0131)
MTHU018302 (LOINC Version 232)
C0017184 (UMLS CUI 2011AA)
90734009 (SNOMED CT 2011_0131)
CL383594 (UMLS CUI 2011AA)
C0043096 (UMLS CUI 2011AA)
89362005 (SNOMED CT 2011_0131)
10047895 (MedDRA 14.1)
MTHU020881 (LOINC Version 232)
783.21 (ICD-9-CM Version 2011)
E12228 (CTCAE 1105E)
C0021641 (UMLS CUI 2011AA)
67866001 (SNOMED CT 2011_0131)
MTHU019392 (LOINC Version 232)
C1257987 (UMLS CUI 2011AA)
109086001 (SNOMED CT 2011_0131)
C2267008 (UMLS CUI 2011AA)
C0038766 (UMLS CUI 2011AA)
C1579432 (UMLS CUI 2011AA)